Esteve Healthcare Overview
- Year Founded
-
1929
- Status
-
Acquired/Merged
- Employees
-
2,000
- Latest Deal Type
-
Corporate
- Financing Rounds
-
2
- Investments
-
10
Esteve Healthcare General Information
Description
Developer of pharmaceutical products intended for Improving people's lives. The company specializes in developing generic drugs, veterinary drugs and vaccines as well as offers research and development assistance in the field of biotechnology and pharmaceutical chemicals.
Contact Information
Website
www.esteve.es(Operating Subsidiary)
Corporate Office
- Passeig de la Zona Franca, 109
- 4th Floor, Planta
- 08038 Barcelona
- Spain
Corporate Office
- Passeig de la Zona Franca, 109
- 4th Floor, Planta
- 08038 Barcelona
- Spain
Esteve Healthcare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Esteve Healthcare Comparisons
Industry
Financing
Details
Esteve Healthcare Competitors (25)
One of Esteve Healthcare’s 25 competitors is Biocon, a Formerly PE-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biocon | Formerly PE-Backed | Bengaluru, India | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria |
Esteve Healthcare Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Esteve Healthcare Patents
Esteve Healthcare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3230908-A1 | Oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection | Pending | 20-Sep-2021 | ||
| EP-4404933-A1 | Oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection | Pending | 20-Sep-2021 | ||
| JP-2024531809-A | Oxadiazaspiro compounds for use in the treatment of motor neuron degeneration or in neuroprotection - patents.com | Pending | 20-Sep-2021 | ||
| US-20250002503-A1 | Oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection | Pending | 20-Sep-2021 | ||
| AU-2022346825-A1 | Oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection | Pending | 20-Sep-2021 | C07D498/10 |
Esteve Healthcare Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Esteve Healthcare Investments & Acquisitions (10)
Esteve Healthcare’s most recent deal was a Corporate Asset Purchase with Takeda Pharmaceutical (Oncology Product MEPACT). The deal was made on 06-Feb-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Takeda Pharmaceutical (Oncology Product MEPACT) | 06-Feb-2025 | Corporate Asset Purchase | Buildings and Property | ||
| HRA Pharma Rare Diseases | 10-Jul-2024 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Uquifa (Lliçà De Vall Facilities in Barcelona) | 04-Feb-2022 | Corporate Asset Purchase | Other Pharmaceuticals and Biotechnology | ||
| Hangzhou Jiuyuan Gene Engineering Co. | 18-Sep-2020 | Secondary Transaction - Private | Biotechnology | ||
| Riemser Pharma | 25-Feb-2020 | Merger/Acquisition | Distributors (Healthcare) |
Esteve Healthcare Exits (3)
Esteve Healthcare’s most recent exit was on 18-Sep-2020 from Hangzhou Jiuyuan Gene Engineering Co.. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Hangzhou Jiuyuan Gene Engineering Co. | 18-Sep-2020 | Completed |
|
||
| Hangzhou Jiuyuan Gene Engineering Co. | 28-Nov-2008 | Completed |
|
||
| Windtree Therapeutics | 20-Jun-2003 | PIPE | Completed |
|
Esteve Healthcare Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| HRA Pharma Rare Diseases | Chatillon, France | 1996 |
Esteve Healthcare FAQs
-
When was Esteve Healthcare founded?
Esteve Healthcare was founded in 1929.
-
Where is Esteve Healthcare headquartered?
Esteve Healthcare is headquartered in Barcelona, Spain.
-
What is the size of Esteve Healthcare?
Esteve Healthcare has 2,000 total employees.
-
What industry is Esteve Healthcare in?
Esteve Healthcare’s primary industry is Drug Discovery.
-
Is Esteve Healthcare a private or public company?
Esteve Healthcare is a Private company.
-
What is Esteve Healthcare’s current revenue?
The current revenue for Esteve Healthcare is .
-
Who are Esteve Healthcare’s competitors?
Biocon, Merck & Co., Genentech, Novartis, and Pfizer Manufacturing Austria are some of the 25 competitors of Esteve Healthcare.
-
When was Esteve Healthcare acquired?
Esteve Healthcare was acquired on 17-May-2023.
-
Who acquired Esteve Healthcare?
Esteve Healthcare was acquired by Autajon Packaging Durero.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
